Literature DB >> 2676515

High-resolution X-ray diffraction study of the complex between endothiapepsin and an oligopeptide inhibitor: the analysis of the inhibitor binding and description of the rigid body shift in the enzyme.

A Sali1, B Veerapandian, J B Cooper, S I Foundling, D J Hoover, T L Blundell.   

Abstract

The conformation of the synthetic renin inhibitor CP-69,799, bound to the active site of the fungal aspartic proteinase endothiapepsin (EC 3.4.23.6), has been determined by X-ray diffraction at 1.8 A resolution and refined to the crystallographic R factor of 16%. CP-69,799 is an oligopeptide transition--state analogue inhibitor that contains a new dipeptide isostere at the P1-P1' position. This dipeptide isostere is a nitrogen analogue of the well-explored hydroxyethylene dipeptide isostere, wherein the tetrahedral P1' C alpha atom has been replaced by trigonal nitrogen. The inhibitor binds in the extended conformation, filling S4 to S3' pockets, with hydroxyl group of the P1 residue positioned symmetrically between the two catalytic aspartates of the enzyme. Interactions between the inhibitor and the enzyme include 12 hydrogen bonds and extensive van der Waals contacts in all the pockets, except for S3'. The crystal structure reveals a bifurcated orientation of the P2 histidine side chain and an interesting relative rotation of the P3 phenyl ring to accommodate the cyclohexyl side chain at P1. The binding of the inhibitor to the enzyme, while producing no large distortions in the enzyme active site cleft, results in small but significant change in the relative orientation of the two endothiapepsin domains. This structural change may represent the action effected by the proteinase as it distorts its substrate towards the transition state for proteolytic cleavage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2676515      PMCID: PMC401145          DOI: 10.1002/j.1460-2075.1989.tb08340.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  Construction of a model for the three-dimensional structure of human renal renin.

Authors:  W Carlson; M Karplus; E Haber
Journal:  Hypertension       Date:  1985 Jan-Feb       Impact factor: 10.190

2.  Structure and refinement of penicillopepsin at 1.8 A resolution.

Authors:  M N James; A R Sielecki
Journal:  J Mol Biol       Date:  1983-01-15       Impact factor: 5.469

3.  Electronic distributions within protein phenylalanine aromatic rings are reflected by the three-dimensional oxygen atom environments.

Authors:  K A Thomas; G M Smith; T B Thomas; R J Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

4.  Potent new inhibitors of human renin.

Authors:  M Szelke; B Leckie; A Hallett; D M Jones; J Sueiras; B Atrash; A F Lever
Journal:  Nature       Date:  1982-10-07       Impact factor: 49.962

5.  Three-dimensional structure of the complex of the Rhizopus chinensis carboxyl proteinase and pepstatin at 2.5-A resolution.

Authors:  R Bott; E Subramanian; D R Davies
Journal:  Biochemistry       Date:  1982-12-21       Impact factor: 3.162

6.  The active site of aspartic proteinases.

Authors:  L Pearl; T Blundell
Journal:  FEBS Lett       Date:  1984-08-20       Impact factor: 4.124

7.  Computer graphics modelling of human renin. Specificity, catalytic activity and intron-exon junctions.

Authors:  B L Sibanda; T Blundell; P M Hobart; M Fogliano; J S Bindra; B W Dominy; J M Chirgwin
Journal:  FEBS Lett       Date:  1984-08-20       Impact factor: 4.124

8.  Structure of ethanol-inhibited porcine pepsin at 2-A resolution and binding of the methyl ester of phenylalanyl-diiodotyrosine to the enzyme.

Authors:  N S Andreeva; A S Zdanov; A E Gustchina; A A Fedorov
Journal:  J Biol Chem       Date:  1984-09-25       Impact factor: 5.157

9.  Three-dimensional structure, specificity and catalytic mechanism of renin.

Authors:  T Blundell; B L Sibanda; L Pearl
Journal:  Nature       Date:  1983 Jul 21-27       Impact factor: 49.962

10.  Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin.

Authors:  M N James; A Sielecki; F Salituro; D H Rich; T Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

View more
  13 in total

1.  Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes.

Authors:  N S Andreeva; L D Rumsh
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes.

Authors:  M D Eldridge; C W Murray; T R Auton; G V Paolini; R P Mee
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

3.  Penicillopepsin-JT2, a recombinant enzyme from Penicillium janthinellum and the contribution of a hydrogen bond in subsite S3 to k(cat).

Authors:  Q N Cao; M Stubbs; K Q Ngo; M Ward; A Cunningham; E F Pai; G C Tu; T Hofmann
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

4.  Crystal structure of human pepsin and its complex with pepstatin.

Authors:  M Fujinaga; M M Chernaia; N I Tarasova; S C Mosimann; M N James
Journal:  Protein Sci       Date:  1995-05       Impact factor: 6.725

5.  A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica.

Authors:  D Bailey; J B Cooper
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

6.  Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.

Authors:  A M Silva; A Y Lee; S V Gulnik; P Maier; J Collins; T N Bhat; P J Collins; R E Cachau; K E Luker; I Y Gluzman; S E Francis; A Oksman; D E Goldberg; J W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

7.  Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.

Authors:  E T Baldwin; T N Bhat; S Gulnik; M V Hosur; R C Sowder; R E Cachau; J Collins; A M Silva; J W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

8.  Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents.

Authors:  C Abad-Zapatero; R Goldman; S W Muchmore; C Hutchins; K Stewart; J Navaza; C D Payne; T L Ray
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

9.  Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases.

Authors:  B Veerapandian; J B Cooper; A Sali; T L Blundell; R L Rosati; B W Dominy; D B Damon; D J Hoover
Journal:  Protein Sci       Date:  1992-03       Impact factor: 6.725

10.  Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling.

Authors:  N Thanki; J K Rao; S I Foundling; W J Howe; J B Moon; J O Hui; A G Tomasselli; R L Heinrikson; S Thaisrivongs; A Wlodawer
Journal:  Protein Sci       Date:  1992-08       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.